Ticketmaster planning to verify if fans have received a COVID-19 vaccine or tested negative before concerts

Whenever it's possible to attend large concerts again, it seems proof that you've received a COVID-19 vaccine — or at least tested negative for the coronavirus — will be a requirement.
Ticketmaster is working on a plan to use "smart phones to verify fans' vaccination status or whether they've tested negative for the coronavirus within a 24 to 72 hour window" before they can attend events once concerts return, Billboard reported on Wednesday.
This would evidently entail having a third party health pass company verify a person's vaccination status, or verify that they've recently tested negative for the coronavirus, after they purchase a ticket. Once that has been confirmed, Ticketmaster, which wouldn't have access to medical records, would issue the necessary credentials. But "if a fan tested positive or didn't take a test to verify their status, they would not be granted access to the event," Billboard says.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Ticketmaster President Mark Yovich told Billboard that "we're already seeing many third-party health care providers prepare to handle the vetting — whether that is getting a vaccine, taking a test, or other methods of review and approval — which could then be linked via a digital ticket so everyone entering the event is verified." He added that the company hopes to "provide enough flexibility and options that venues and fans have multiple paths to return to events."
News of Ticketmaster's plan comes after Pfizer announced this week that an early analysis suggested its COVID-19 vaccine candidate is more than 90 percent effective, although it still needs to be proven to be safe and approved by the Food and Drug Administration. If it does get approved, Dr. Anthony Fauci, the nation's top infectious disease expert, has predicted that the average person may be able to get it by April 2021.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Trump pauses Ukraine intelligence sharing
Speed Read The decision is intended to pressure Ukrainian President Volodymyr Zelenskyy into peace negotiations with Vladimir Putin
By Peter Weber, The Week US Published
-
Supreme Court rules against Trump on aid freeze
Speed Read The court rejected the president's request to freeze nearly $2 billion in payments for foreign humanitarian work
By Rafi Schwartz, The Week US Published
-
'If you keep people permanently unhappy, you cannot have a stable society'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
By Peter Weber, The Week US Published
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US Published
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published